Malign Melanomda Tedavi Prensiplerimiz ve Sonuçlarımız

Cilt: 28 Sayı: 1 1 Mart 2002
  • Güzin Yeşim Özgenel
  • Ramazan Kahveci
  • Mesut Özcan
  • Selçuk Akın
  • Serhat Özbek
  • Gülaydan Filiz
PDF İndir
EN TR

Our Treatment Principles and Results in Malignant Melanoma

Öz

In this study, our experiences with 30 cases who were treated for melanoma between the years 1993-2001 in the Department of Plastic and Reconstructive Surgery of Uludağ University Medical School were presented. These cases were evaluated according to the age, sex, localization, histologic type and level, nodal status and recurrence. Eighteen cases were men and 12 cases were women. The mean age was 61 years. Histologic examinations revealed that 17 cases were nodular, 6 cases were superficial, 4 cases were acral lentiginous and 3 cases were lentigo melanoma. According to the Clark's level, 43.3% of the cases were classified in level IV-V, 13.3% in level III and 43.3% in level II. At the admission, 53.3% of the cases were found to have regional lymph node metastasis. Local recurrence was seen in 10% of the cases at different time points following the operation. We excised the lesions with 3-cm free margin including the fascia. Regional lymph node dissection was performed in cases who had regional lymph node metastatis. In cases who had no lymph node metastasis, sentinel lymph node biopsy was performed.

Anahtar Kelimeler

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

-

Yazarlar

Güzin Yeşim Özgenel Bu kişi benim

Ramazan Kahveci Bu kişi benim

Mesut Özcan Bu kişi benim

Selçuk Akın Bu kişi benim

Serhat Özbek Bu kişi benim

Gülaydan Filiz Bu kişi benim

Yayımlanma Tarihi

1 Mart 2002

Gönderilme Tarihi

1 Mart 2002

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2002 Cilt: 28 Sayı: 1

Kaynak Göster

APA
Özgenel, G. Y., Kahveci, R., Özcan, M., Akın, S., Özbek, S., & Filiz, G. (2002). Our Treatment Principles and Results in Malignant Melanoma. Journal of Uludağ University Medical Faculty, 28(1), 13-16. https://izlik.org/JA74EX27LP
AMA
1.Özgenel GY, Kahveci R, Özcan M, Akın S, Özbek S, Filiz G. Our Treatment Principles and Results in Malignant Melanoma. Uludağ Tıp Derg. 2002;28(1):13-16. https://izlik.org/JA74EX27LP
Chicago
Özgenel, Güzin Yeşim, Ramazan Kahveci, Mesut Özcan, Selçuk Akın, Serhat Özbek, ve Gülaydan Filiz. 2002. “Our Treatment Principles and Results in Malignant Melanoma”. Journal of Uludağ University Medical Faculty 28 (1): 13-16. https://izlik.org/JA74EX27LP.
EndNote
Özgenel GY, Kahveci R, Özcan M, Akın S, Özbek S, Filiz G (01 Mart 2002) Our Treatment Principles and Results in Malignant Melanoma. Journal of Uludağ University Medical Faculty 28 1 13–16.
IEEE
[1]G. Y. Özgenel, R. Kahveci, M. Özcan, S. Akın, S. Özbek, ve G. Filiz, “Our Treatment Principles and Results in Malignant Melanoma”, Uludağ Tıp Derg, c. 28, sy 1, ss. 13–16, Mar. 2002, [çevrimiçi]. Erişim adresi: https://izlik.org/JA74EX27LP
ISNAD
Özgenel, Güzin Yeşim - Kahveci, Ramazan - Özcan, Mesut - Akın, Selçuk - Özbek, Serhat - Filiz, Gülaydan. “Our Treatment Principles and Results in Malignant Melanoma”. Journal of Uludağ University Medical Faculty 28/1 (01 Mart 2002): 13-16. https://izlik.org/JA74EX27LP.
JAMA
1.Özgenel GY, Kahveci R, Özcan M, Akın S, Özbek S, Filiz G. Our Treatment Principles and Results in Malignant Melanoma. Uludağ Tıp Derg. 2002;28:13–16.
MLA
Özgenel, Güzin Yeşim, vd. “Our Treatment Principles and Results in Malignant Melanoma”. Journal of Uludağ University Medical Faculty, c. 28, sy 1, Mart 2002, ss. 13-16, https://izlik.org/JA74EX27LP.
Vancouver
1.Güzin Yeşim Özgenel, Ramazan Kahveci, Mesut Özcan, Selçuk Akın, Serhat Özbek, Gülaydan Filiz. Our Treatment Principles and Results in Malignant Melanoma. Uludağ Tıp Derg [Internet]. 01 Mart 2002;28(1):13-6. Erişim adresi: https://izlik.org/JA74EX27LP

ISSN: 1300-414X, e-ISSN: 2645-9027

Uludağ Üniversitesi Tıp Fakültesi Dergisi "Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License" ile lisanslanmaktadır.


Creative Commons License
Journal of Uludag University Medical Faculty is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

2023